This article is
- freely available
HIV-1 Ribonuclease H: Structure, Catalytic Mechanism and Inhibitors
Department of Microbiology and Immunology, McGill University, Lyman Duff Medical Building (D6), 3775 University St., Montreal, QC, H3A 2B4, Canada
* Author to whom correspondence should be addressed.
Received: 28 January 2010; in revised form: 22 March 2010 / Accepted: 24 March 2010 / Published: 30 March 2010
Abstract: Since the human immunodeficiency virus (HIV) was discovered as the etiological agent of acquired immunodeficiency syndrome (AIDS), it has encouraged much research into antiviral compounds. The reverse transcriptase (RT) of HIV has been a main target for antiviral drugs. However, all drugs developed so far inhibit the polymerase function of the enzyme, while none of the approved antiviral agents inhibit specifically the necessary ribonuclease H (RNase H) function of RT. This review provides a background on structure-function relationships of HIV-1 RNase H, as well as an outline of current attempts to develop novel, potent chemotherapeutics against a difficult drug target.
Keywords: HIV; reverse transcriptase; RNase H; inhibitors; drug resistance
Article StatisticsClick here to load and display the download statistics.
Notes: Multiple requests from the same IP address are counted as one view.
Cite This Article
MDPI and ACS Style
Beilhartz, G.L.; Götte, M. HIV-1 Ribonuclease H: Structure, Catalytic Mechanism and Inhibitors. Viruses 2010, 2, 900-926.
Beilhartz GL, Götte M. HIV-1 Ribonuclease H: Structure, Catalytic Mechanism and Inhibitors. Viruses. 2010; 2(4):900-926.
Beilhartz, Greg L.; Götte, Matthias. 2010. "HIV-1 Ribonuclease H: Structure, Catalytic Mechanism and Inhibitors." Viruses 2, no. 4: 900-926.